Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparing the starting time of tacrolimus administration in kidney transplant recipients
IRCT201604253043N11Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2016
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tacrolimus in kidney allograft rejection, sponsored by Tehran University of Medical Sciences. Started May 2016; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney allograft rejection
Beyond the preview
Go deeper on IRCT201604253043N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201604253043N11.